Clinical TrialsSearch results
Number of results: 871
Other
- Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery (a randomized, double-blind, multi-center, placebo-controlled study) Additional study:Gastrointestinal transit time as an indicator
- Colon cancer (Sigmoidal and Rectosigmoidal regions)
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-03-24
Other
- Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery (a randomized, double-blind, multi-center, placebo-controlled study)
- Colon cancer including RS cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Completed
- Phase 2 trial of FOLFIRI plus ziv-aflibercept in patients with colorectal cancer previously treated with oxaliplatin, fluoropyrimidins, bevacizumab, and trifluridine/tipiracil
- colorectal cancer
- Matsumoto Toshihiko
- 2019-12-19
Recruiting
- Clinical trial for prevention of anti-EGFR antibody induced acneiform eruption
- Colorectal cancer
- Hiroshi Matsuoka
- 2024-04-08
Recruiting
- NUSSG-01 study
- Colorectal cancer
- Ogura Atsushi
- 2021-08-20
Recruiting
- PRABITAS study
- colorectal cancer
- Taniguchi Hiroya
- 2023-12-21
Other
- A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-01
Other
- A multicenter phaseII study of FOLFIRI as FOLFOX refractory second-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with honozygous for UGT1A1: (FLIGHT2)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-10
Other
- Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancer
- colorectal cancer
- Tsukuba Cancer Clinical Trial Group
- 2008-12-03
Other
- E-BiTS study
- colorectal cancer
- Taniguchi Hiroya
- 2022-11-01